Cytek Biosciences Inc
(FRA:8EQ)
€
5.75
0.15 (2.68%)
Market Cap: 802.24 Mil
Enterprise Value: 567.61 Mil
PE Ratio: 0
PB Ratio: 2.12
GF Score: 62/100 - Q1 2024 Cytek Biosciences Inc Earnings Call TranscriptMay 08, 2024€5.85 (-0.85%)Earnings
- Q4 2023 Cytek Biosciences Inc Earnings Call TranscriptFeb 28, 2024€3.4Earnings
- Cytek Biosciences Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 Cytek Biosciences Inc Earnings Call TranscriptNov 07, 2023€4 (-0.50%)Earnings
- Cytek Biosciences Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 27, 2023
- Cytek Biosciences Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2023
- Q2 2023 Cytek Biosciences Inc Earnings Call TranscriptAug 08, 2023€8.2Earnings
- Cytek Biosciences Inc at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023
- Q1 2023 Cytek Biosciences Inc Earnings Call TranscriptMay 09, 2023€10.4 (-1.89%)Earnings
- Q4 2022 Cytek Biosciences Inc Earnings Call TranscriptFeb 28, 2023€9.85 (-5.29%)Earnings
- Cytek Biosciences Inc To Acquire Flow Cytometry and Imaging Business From DiaSorin- M&A Call TranscriptFeb 13, 2023
- Cytek Biosciences Inc at Piper Sandler Healthcare Conference TranscriptDec 01, 2022
- Cytek Biosciences Inc at Credit Suisse Healthcare Conference TranscriptNov 09, 2022
- Q3 2022 Cytek Biosciences Inc Earnings Call TranscriptNov 09, 2022€14.2 (-2.07%)Earnings
- Cytek Biosciences Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 14, 2022
- Q2 2022 Cytek Biosciences Inc Earnings Call TranscriptAug 10, 2022€14.2 (-2.07%)Earnings
- Cytek Biosciences Inc Corporate Analyst Meeting TranscriptJun 22, 2022
- Q1 2022 Cytek Biosciences Inc Earnings Call TranscriptMay 11, 2022€7.5 (+2.74%)Earnings
- Q4 2021 Cytek Biosciences Inc Earnings Call TranscriptFeb 23, 2022€11.7 (-4.10%)Earnings
- Q3 2021 Cytek Biosciences Inc Earnings Call TranscriptNov 08, 2021€21 (+1.94%)Earnings
- Cytek Biosciences Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2021
Cytek Biosciences Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
Sep 27, 2023 / 05:15PM GMT
Release Date Price:
€5.9
(-1.67%)
Ross Osborn Cantor Fitzgerald;Analyst
Good afternoon, my name is Ross Osborn, I'm the MedTech, life science tools, and diagnostics analyst at Cantor. And today we have the honor of hosting Cytek Biosciences, including the CEO, Wenbin Jiang; and Patrik Jeanmonod. Apologies for the pronunciation.
But turning off, would you just provide a brief a brief background on yourselves.
Wenbin Jiang Cytek Biosciences
Inc. - CEO & Chairman of the Board
Thank you, Ross. I'm Wenbin Jiang, CEO and the Co-Founder of Cytek. And the company was founded 8.5 years ago and has been an exciting journey, and the company went public in '21.
Ross Osborn Cantor Fitzgerald;Analyst
Great.
Patrik Jeanmonod Cytek Biosciences;Ross
Inc. - CFO
And I'm Patrik Jeanmonod, I'm the CFO. I joined Cytek in 2018. I have about 20 plus years in life science industry experience working for PE-backed, VC-backed, family owned organization, early stage and late stage.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)